BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 35313837)

  • 1. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
    Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
    BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of current oral HPV infection among 100 betel nut chewers or cigarette smokers in Northern Taiwan.
    Wang CP; Chen TC; Chen HH; Hsu WL; Chang YL
    J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):203-208. PubMed ID: 29636296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.
    Al-Swiahb JN; Huang CC; Fang FM; Chuang HC; Huang HY; Luo SD; Chen CH; Chen CM; Chien CY
    Arch Otolaryngol Head Neck Surg; 2010 May; 136(5):502-8. PubMed ID: 20479383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic stratification of oropharyngeal cancer patients in a betel nut chewing and low HPV area.
    Lee HP; Lee CC
    J Otolaryngol Head Neck Surg; 2023 Apr; 52(1):27. PubMed ID: 37081578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer.
    Huang CC; Su YC; Chang CC; Lee WT; Ou CY; Wu YH; Wu SY; Lai YH; Huang JS; Chen KC; Hsueh WT; Tsai ST; Yen CJ; Chang JY; Tsai ML; Lin CL; Weng YL; Yang HC; Chen YS; Hsiao JR; Chang JS
    Cancer Med; 2021 Jun; 10(12):4075-4086. PubMed ID: 33949155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and treatment outcome of oropharyngeal squamous cell carcinoma in an endemic betel quid region.
    Chen TC; Wu CT; Ko JY; Yang TL; Lou PJ; Wang CP; Chang YL
    Sci Rep; 2020 Jan; 10(1):526. PubMed ID: 31949181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population.
    Evans M; Newcombe R; Fiander A; Powell J; Rolles M; Thavaraj S; Robinson M; Powell N
    BMC Cancer; 2013 May; 13():220. PubMed ID: 23634887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer.
    Dahlstrom KR; Anderson KS; Field MS; Chowell D; Ning J; Li N; Wei Q; Li G; Sturgis EM
    Cancer; 2017 Dec; 123(24):4886-4894. PubMed ID: 28898394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of alcohol consumption, betel nut chewing, and cigarette smoking with mortality in patients with head and neck cancer among the Taiwanese population: A nationwide population-based cohort study.
    Su MJ; Ho CH; Yeh CC
    Cancer Epidemiol; 2024 Apr; 89():102526. PubMed ID: 38266595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
    JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
    Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
    Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary High-Risk Human Papillomavirus (HPV) DNA as a Biomarker for HPV-Driven Head and Neck Cancers.
    Ekanayake Weeramange C; Liu Z; Hartel G; Li Y; Vasani S; Langton-Lockton J; Kenny L; Morris L; Frazer I; Tang KD; Punyadeera C
    J Mol Diagn; 2021 Oct; 23(10):1334-1342. PubMed ID: 34325059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
    Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
    Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of oral nonmalignant lesions associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan: an integrated molecular and epidemiologic study.
    Chen PC; Pan CC; Kuo C; Lin CP
    Arch Pathol Lab Med; 2006 Jan; 130(1):57-61. PubMed ID: 16390239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and outcomes of oropharyngeal carcinoma related to high-risk non-human papillomavirus16 viral subtypes.
    Varier I; Keeley BR; Krupar R; Patsias A; Dong J; Gupta N; Parasher AK; Genden EM; Miles BA; Teng M; Bakst RL; Gupta V; Misiukiewicz KJ; Chiao EY; Scheurer ME; Laban S; Zhang D; Ye F; Cui M; Demicco EG; Posner MR; Sikora AG
    Head Neck; 2016 Sep; 38(9):1330-7. PubMed ID: 27080140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Competing mortality in oropharyngeal carcinoma according to human papillomavirus status.
    Lop J; García J; López M; Taberna M; Mena M; Alemany L; Quer M; León X
    Head Neck; 2019 May; 41(5):1328-1334. PubMed ID: 30549389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas.
    Huang SH; Xu W; Waldron J; Siu L; Shen X; Tong L; Ringash J; Bayley A; Kim J; Hope A; Cho J; Giuliani M; Hansen A; Irish J; Gilbert R; Gullane P; Perez-Ordonez B; Weinreb I; Liu FF; O'Sullivan B
    J Clin Oncol; 2015 Mar; 33(8):836-45. PubMed ID: 25667292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
    Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
    Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.